The global anxiety and panic disorders drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anxiety disorders are associated with the post-traumatic stress disorder (PTSD), phobias, and obsessive-compulsive disorder. Anxiety and panic disorders correspond with a high burden of illness as they are psychiatric disorders. Attributed to the increasing cases of anxiety disorders, there is a need for the development of novel drugs for its effective treatment. This is likely to drive the growth of the market during the forecast period. Another key trend observed in the market includes the growing prevalence of anxiety and panic disorders in the developed countries, such as the US. Based on diagnostic interview data from National Comorbidity Survey Replication, an estimated 4.7% of US adults experience panic disorder at some time in their lives. 

This is further backed by the growing sedentary lifestyle in the developed countries, high disposable income, and increased per capita healthcare expenditure. All these factors are positively influencing the demand for anxiety and panic disorders drugs in such countries. Additionally, various reimbursement policies offered in developed countries for therapies and medication influences the market positively. At present, the two types of drugs available in the market can be largely segmented into antidepressant drugs, and anxiolytic drugs. Of the two, the antidepressant drugs could gross maximum revenue in the next couple of years on the back of the launch of newer selective serotonin reuptake inhibitor (SSRIs) with safer side effects. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Drug Class

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Anxiety and Panic Disorders Drugs Market Report by Segment

By Drug Class

    • Antidepressant Drugs

    • Anxiolytic Drugs

Global Anxiety and Panic Disorders Drugs Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa